Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Rizza suggested that some of the Treloar's pupils, if possible, should receive NHS material.

  • Read more about Dr Rizza suggested that some of the Treloar's pupils, if possible, should receive NHS material.

Dr Aronstam stated that Treloar's patients had already had five different types of concentrates and he prefered not to "confine [himself] to a single Concentrate."

  • Read more about Dr Aronstam stated that Treloar's patients had already had five different types of concentrates and he prefered not to "confine [himself] to a single Concentrate."

Dr Swinburne (Leeds Haemophilia Centre) suggested that it was wise that the patient be treated with one product and Hemofil was recommended.

  • Read more about Dr Swinburne (Leeds Haemophilia Centre) suggested that it was wise that the patient be treated with one product and Hemofil was recommended.

Following two trials, Dr Aronstam recognised the potential where prophylaxis reduced the frequency of bleeding episodes and the potential danger of hyper-transfusion with blood products.

  • Read more about Following two trials, Dr Aronstam recognised the potential where prophylaxis reduced the frequency of bleeding episodes and the potential danger of hyper-transfusion with blood products.

Stephen Nicholls recollected that prophylaxis treatment was really pushed at Treloar's.

  • Read more about Stephen Nicholls recollected that prophylaxis treatment was really pushed at Treloar's.

Dr Aronstam stated in a letter that the use of prophylaxis was a routine at Treloar's "in many clinical situations" and described the programme as "admittedly enthusiastic".

  • Read more about Dr Aronstam stated in a letter that the use of prophylaxis was a routine at Treloar's "in many clinical situations" and described the programme as "admittedly enthusiastic".

Dr Iain Frew, the home clinician of a Treloar's student, wrote to Dr Aronstam regarding the higher doses of cryoprecipitate provided by Treloar's.

  • Read more about Dr Iain Frew, the home clinician of a Treloar's student, wrote to Dr Aronstam regarding the higher doses of cryoprecipitate provided by Treloar's.

In a letter to Dr Maycock, Dr Rainsford stated that the Treloar's students had not been adequately treated with AHG before he had arrived at the school.

  • Read more about In a letter to Dr Maycock, Dr Rainsford stated that the Treloar's students had not been adequately treated with AHG before he had arrived at the school.

Blood Concentrate products were most probably first used at Treloar's after March 1969.

  • Read more about Blood Concentrate products were most probably first used at Treloar's after March 1969.

In 1977 cryoprecipitate and NHS factor concentrates were both used at Treloar's, as well as four commercial products.

  • Read more about In 1977 cryoprecipitate and NHS factor concentrates were both used at Treloar's, as well as four commercial products.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 823
  • Page 824
  • Page 825
  • Page 826
  • Current page 827
  • Page 828
  • Page 829
  • Page 830
  • Page 831
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.